Latest News
March 10, 2022
Bayer to sell its Environmental Science Professional business to Cinven for 2.6 billion U.S. dollars
February 21, 2022
Not intended for U.S. and UK Media
Bayer’s new treatment Kerendia® (finerenone) approved in EU for adult patients with chronic kidney disease associated with type 2 diabetes
Our Stories